Congenital cytomegalovirus: understanding the long-term outcomes and identifying opportunities for secondary prevention

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cytomegalovirus is a herpesvirus that can be transmitted from mother to baby during pregnancy. Congenital cytomegalovirus (cCMV) can cause damage to the developing central nervous system leading to long-term disabilities including cerebral palsy and hearing loss. This epidemiological research program seeks to investigate cCMV risk factors and burden, opportunities for early detection of neuro-developmental disabilities and to study the effects of postnatal antiviral therapies in this population.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epidemiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cerebral palsy | cytomegalovirus (CMV) | early detection | neurodevelopmental disorders | population health